Biotech Orphans Seek Homes

The American Society of Clinical Oncology (ASCO) annual meeting is full of orphans looking for a home.

By orphans, I mean beaten down drug and biotech companies long left for dead by much of Wall Street. These are the companies that have blown-up drugs -- and the bottomed-out stock prices to go along with them -- but are trying to make a comeback, either by resurrecting old drugs or starting from scratch with something else in the pipeline.

One medical conference does not a comeback make, but the ASCO meeting is a good place to kick the tires on some of these bio-orphans and get started on some further fundamental research. ...